our approach using fresh human tumors as both targets in cytotoxicity assays and stimulators in proliferative assays with other appropriate controls makes possible a careful analysis of the reactivities present following either direct expansion in interleukin 2 ( il-2 ) or following mixed lymphocyte tumor interaction and subsequent limiting dilution cloning .
C0086418
human
C0021756
interleukin 2